Charles River Labs SVP Michael Knell sells $1.73m in stock

Michael Knell, Senior Vice President of Finance and Chief Accounting Officer at Charles River Laboratories International, sold 6,645 shares of the company's stock on August 6, 2026, amounting to around $1.73 million. The shares were sold at prices between $258.53 and $265.17 per share, as Charles River Labs' stock is trading near its 52-week high of $277.07, following an 86% return in the past year.

Mr. Knell also bought 2,345 shares through stock options on the same day, spending about $459,909 at prices ranging from $179.66 to $208.44 per share. Currently, he holds 11,852 shares of Charles River Laboratories International common stock. Charles River Laboratories recently reported strong second-quarter 2026 earnings and revenue, exceeding Wall Street expectations.

The company's adjusted earnings per share were $3.02, surpassing the forecast of $2.74, and revenue reached $1 billion, surpassing the anticipated $976.13 million. Following these results, Charles River Labs raised its full-year outlook. Analyst firms have responded positively to these developments, with TD Cowen raising its price target to $300, JPMorgan upgrading the stock rating to Overweight, and Evercore ISI also raising its price target. These upgrades reflect growing confidence in Charles River Labs' performance and future prospects.